Matches in Nanopublications for { ?s ?p "[We sought to overcome this limitation by designing a non-MHC-restricted, chimeric antigen receptor (CAR) targeting the high molecular weight melanoma-associated antigen (HMW-MAA), which is highly expressed on more than 90% of human melanomas but has a restricted distribution in normal tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 24 of
24
with 100 items per page.
- assertion description "[We sought to overcome this limitation by designing a non-MHC-restricted, chimeric antigen receptor (CAR) targeting the high molecular weight melanoma-associated antigen (HMW-MAA), which is highly expressed on more than 90% of human melanomas but has a restricted distribution in normal tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP252569.RA6Qzd1-geJelmxQnsmG0Ef_isoMS9SVsQYvnMTYNzyww130_assertion description "[We sought to overcome this limitation by designing a non-MHC-restricted, chimeric antigen receptor (CAR) targeting the high molecular weight melanoma-associated antigen (HMW-MAA), which is highly expressed on more than 90% of human melanomas but has a restricted distribution in normal tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP252569.RA6Qzd1-geJelmxQnsmG0Ef_isoMS9SVsQYvnMTYNzyww130_provenance.
- NP338543.RA3D1HcGMIjdA2WssJfzV-DQLqIgcrodIp7xffxe8xuf4130_assertion description "[We sought to overcome this limitation by designing a non-MHC-restricted, chimeric antigen receptor (CAR) targeting the high molecular weight melanoma-associated antigen (HMW-MAA), which is highly expressed on more than 90% of human melanomas but has a restricted distribution in normal tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP338543.RA3D1HcGMIjdA2WssJfzV-DQLqIgcrodIp7xffxe8xuf4130_provenance.
- NP642221.RAU8EvyIC2h2nDxJrvYVjXE0-Ndj60qy9LaV7WDjem6Qg130_assertion description "[We sought to overcome this limitation by designing a non-MHC-restricted, chimeric antigen receptor (CAR) targeting the high molecular weight melanoma-associated antigen (HMW-MAA), which is highly expressed on more than 90% of human melanomas but has a restricted distribution in normal tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP642221.RAU8EvyIC2h2nDxJrvYVjXE0-Ndj60qy9LaV7WDjem6Qg130_provenance.
- assertion description "[We sought to overcome this limitation by designing a non-MHC-restricted, chimeric antigen receptor (CAR) targeting the high molecular weight melanoma-associated antigen (HMW-MAA), which is highly expressed on more than 90% of human melanomas but has a restricted distribution in normal tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP833714.RAY0FoBCMYF3rcjGxYMU9DhyQrDljh8FahkYa7hz-exCM130_assertion description "[We sought to overcome this limitation by designing a non-MHC-restricted, chimeric antigen receptor (CAR) targeting the high molecular weight melanoma-associated antigen (HMW-MAA), which is highly expressed on more than 90% of human melanomas but has a restricted distribution in normal tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP833714.RAY0FoBCMYF3rcjGxYMU9DhyQrDljh8FahkYa7hz-exCM130_provenance.
- NP710125.RAT1Kx0f1oNdMWyNrlt8euGr9ZBfi2-wSni4cCyMkmbU8130_assertion description "[We sought to overcome this limitation by designing a non-MHC-restricted, chimeric antigen receptor (CAR) targeting the high molecular weight melanoma-associated antigen (HMW-MAA), which is highly expressed on more than 90% of human melanomas but has a restricted distribution in normal tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP710125.RAT1Kx0f1oNdMWyNrlt8euGr9ZBfi2-wSni4cCyMkmbU8130_provenance.
- assertion description "[We sought to overcome this limitation by designing a non-MHC-restricted, chimeric antigen receptor (CAR) targeting the high molecular weight melanoma-associated antigen (HMW-MAA), which is highly expressed on more than 90% of human melanomas but has a restricted distribution in normal tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP806317.RA1f0gyuh3B66UkLUDkZOizO_9So5L-casnCUYX9tiyOU130_assertion description "[We sought to overcome this limitation by designing a non-MHC-restricted, chimeric antigen receptor (CAR) targeting the high molecular weight melanoma-associated antigen (HMW-MAA), which is highly expressed on more than 90% of human melanomas but has a restricted distribution in normal tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP806317.RA1f0gyuh3B66UkLUDkZOizO_9So5L-casnCUYX9tiyOU130_provenance.
- NP806323.RAT17Im-SVPkzTlSfrX3tIT7j2G5WOhu5GXGUKD76Gz0A130_assertion description "[We sought to overcome this limitation by designing a non-MHC-restricted, chimeric antigen receptor (CAR) targeting the high molecular weight melanoma-associated antigen (HMW-MAA), which is highly expressed on more than 90% of human melanomas but has a restricted distribution in normal tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP806323.RAT17Im-SVPkzTlSfrX3tIT7j2G5WOhu5GXGUKD76Gz0A130_provenance.
- NP806325.RAXHoamyIdm4dX-HjjHL2KXOqSdhvn0J-ExpFuGMqXkak130_assertion description "[We sought to overcome this limitation by designing a non-MHC-restricted, chimeric antigen receptor (CAR) targeting the high molecular weight melanoma-associated antigen (HMW-MAA), which is highly expressed on more than 90% of human melanomas but has a restricted distribution in normal tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP806325.RAXHoamyIdm4dX-HjjHL2KXOqSdhvn0J-ExpFuGMqXkak130_provenance.
- assertion description "[We sought to overcome this limitation by designing a non-MHC-restricted, chimeric antigen receptor (CAR) targeting the high molecular weight melanoma-associated antigen (HMW-MAA), which is highly expressed on more than 90% of human melanomas but has a restricted distribution in normal tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We sought to overcome this limitation by designing a non-MHC-restricted, chimeric antigen receptor (CAR) targeting the high molecular weight melanoma-associated antigen (HMW-MAA), which is highly expressed on more than 90% of human melanomas but has a restricted distribution in normal tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We sought to overcome this limitation by designing a non-MHC-restricted, chimeric antigen receptor (CAR) targeting the high molecular weight melanoma-associated antigen (HMW-MAA), which is highly expressed on more than 90% of human melanomas but has a restricted distribution in normal tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We sought to overcome this limitation by designing a non-MHC-restricted, chimeric antigen receptor (CAR) targeting the high molecular weight melanoma-associated antigen (HMW-MAA), which is highly expressed on more than 90% of human melanomas but has a restricted distribution in normal tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1005032.RAldDuobMR_svh_aiLkKx2dxP5Y3eywoRwgLfu10AQlYc130_assertion description "[We sought to overcome this limitation by designing a non-MHC-restricted, chimeric antigen receptor (CAR) targeting the high molecular weight melanoma-associated antigen (HMW-MAA), which is highly expressed on more than 90% of human melanomas but has a restricted distribution in normal tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1005032.RAldDuobMR_svh_aiLkKx2dxP5Y3eywoRwgLfu10AQlYc130_provenance.
- NP806318.RAIBZ_R9W_2DbF5zIyp4mj4-aHzLfOuCc6r6g6h3OruK0130_assertion description "[We sought to overcome this limitation by designing a non-MHC-restricted, chimeric antigen receptor (CAR) targeting the high molecular weight melanoma-associated antigen (HMW-MAA), which is highly expressed on more than 90% of human melanomas but has a restricted distribution in normal tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP806318.RAIBZ_R9W_2DbF5zIyp4mj4-aHzLfOuCc6r6g6h3OruK0130_provenance.
- NP806324.RAIgoQyOFyMyQ2CZ82W1c67qYWY7T92qDdGeUTrvYTaEs130_assertion description "[We sought to overcome this limitation by designing a non-MHC-restricted, chimeric antigen receptor (CAR) targeting the high molecular weight melanoma-associated antigen (HMW-MAA), which is highly expressed on more than 90% of human melanomas but has a restricted distribution in normal tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP806324.RAIgoQyOFyMyQ2CZ82W1c67qYWY7T92qDdGeUTrvYTaEs130_provenance.
- NP806326.RAEukQ0rYvym1WX-X3491ow7ZmzKdmeN4QQlXyJOlcxz4130_assertion description "[We sought to overcome this limitation by designing a non-MHC-restricted, chimeric antigen receptor (CAR) targeting the high molecular weight melanoma-associated antigen (HMW-MAA), which is highly expressed on more than 90% of human melanomas but has a restricted distribution in normal tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP806326.RAEukQ0rYvym1WX-X3491ow7ZmzKdmeN4QQlXyJOlcxz4130_provenance.
- NP838391.RAlK-tbykuSnYsev2dHhANCGF-CCEZqd7afnk-BOTpRWc130_assertion description "[We sought to overcome this limitation by designing a non-MHC-restricted, chimeric antigen receptor (CAR) targeting the high molecular weight melanoma-associated antigen (HMW-MAA), which is highly expressed on more than 90% of human melanomas but has a restricted distribution in normal tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP838391.RAlK-tbykuSnYsev2dHhANCGF-CCEZqd7afnk-BOTpRWc130_provenance.
- assertion description "[We sought to overcome this limitation by designing a non-MHC-restricted, chimeric antigen receptor (CAR) targeting the high molecular weight melanoma-associated antigen (HMW-MAA), which is highly expressed on more than 90% of human melanomas but has a restricted distribution in normal tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP282829.RAjSEGECP1GgulpQdteIAFln_IrtJDOmFUl-AU1SwQjOk130_assertion description "[We sought to overcome this limitation by designing a non-MHC-restricted, chimeric antigen receptor (CAR) targeting the high molecular weight melanoma-associated antigen (HMW-MAA), which is highly expressed on more than 90% of human melanomas but has a restricted distribution in normal tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP282829.RAjSEGECP1GgulpQdteIAFln_IrtJDOmFUl-AU1SwQjOk130_provenance.
- NP806321.RAnpiZ3dzwXVzevHNzfWkgf4DaTVAPtCdB5eVkph0ou6k130_assertion description "[We sought to overcome this limitation by designing a non-MHC-restricted, chimeric antigen receptor (CAR) targeting the high molecular weight melanoma-associated antigen (HMW-MAA), which is highly expressed on more than 90% of human melanomas but has a restricted distribution in normal tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP806321.RAnpiZ3dzwXVzevHNzfWkgf4DaTVAPtCdB5eVkph0ou6k130_provenance.
- NP806322.RAv2EzCL5LVpBunxnWD2ASe3ylZP2tAu_it-qWCHxnGIw130_assertion description "[We sought to overcome this limitation by designing a non-MHC-restricted, chimeric antigen receptor (CAR) targeting the high molecular weight melanoma-associated antigen (HMW-MAA), which is highly expressed on more than 90% of human melanomas but has a restricted distribution in normal tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP806322.RAv2EzCL5LVpBunxnWD2ASe3ylZP2tAu_it-qWCHxnGIw130_provenance.